Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture

This is the authors' abstract. We don't add key points for this paper.

In the original publication Figures 1 and 3 were swapped. The figure legends were not affected. The correct figure order along with the figure legends are shown below. Generic overview of vaccine manufacturing processes. Operation scheme for the manufacturing of Generalized Modules for Membrane Antigens (GMMA) and RNA vaccines. A) GMMA vaccine production using gram-negative bacteria. GMMA are released constantly during bacterial culture and are separated using two sequential TFF steps.[80] B) RNA vaccine production using in vitro transcription. The self-replicating RNA, which encodes the antigen of interest, is transcribed from a DNA template using in vitro transcription, 5′ capped co-transcriptionally, the template DNA is digested and then purified using TFF.[92,93]